Joshua Silverman

Affiliations

  • Executive Chairman at Tao Synergies Inc. (TAOX), 2025-07-02
  • at Femasys Inc (FEMY), 2025-06-27
  • Director at Petros Pharmaceuticals Inc. (PTPI), 2025-02-21
  • Executive Chairman at Ayro Inc. (AYRO), 2024-12-03
  • Interim Ceo, Interim President at Pharmacyte Biotech Inc. (PMCB), 2023-11-22
  • Director at Mymd Pharmaceuticals Inc. (MYMD), 2023-06-09
  • Director at Neurotrope Inc. (NTRP), 2020-12-04
  • Director at Protagenic Therapeutics Inc.w (PTIX), 2020-02-27
  • Director at Tapimmune Inc. (TPIV), 2018-10-17
  • Director at National Holdings Corp (NHLD), 2016-09-13
  • Other at Mgt Capital Investments Inc (MGT), 2016-05-07
  • Director at Alanco Technologies Inc (ALAN), 2016-03-11
  • Large Shareholder at 24Holdings Inc (TWFH), 2013-05-14
  • Large Shareholder at Vringo Inc (VRNG), 2011-12-22
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MYMD $7.55 5,000 $37,771.50 88,775 2021-11-26 Filing
MYMD $7.09 3,266 $23,168.02 83,775 2021-11-24 Filing
MYMD $6.30 6,734 $42,418.14 80,509 2021-11-24 Filing
SNPX $8.30 10,000 $83,000.00 15,000 2021-06-14 Filing
NTRP $1.09 50,000 $54,445.00 100,000 2020-10-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AYRO $0.82 12,740 $10,385.65 395,493 2023-08-01 Filing
AYRO $0.49 11,927 $5,813.22 408,233 2023-05-03 Filing
AYRO $0.71 7,171 $5,107.90 222,827 2023-01-30 Filing
SNPX $1.17 19,012 $22,280.16 38,238 2022-12-16 Filing
AYRO $0.59 7,171 $4,244.51 229,998 2022-11-01 Filing